These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32227212)

  • 1. A murine photothrombotic stroke model with an increased fibrin content and improved responses to tPA-lytic treatment.
    Sun YY; Kuo YM; Chen HR; Short-Miller JC; Smucker MR; Kuan CY
    Blood Adv; 2020 Apr; 4(7):1222-1231. PubMed ID: 32227212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model.
    Kuo YM; Sun YY; Kuan CY
    J Vis Exp; 2021 Jun; (172):. PubMed ID: 34152310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
    van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
    Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
    Molina CA; Ribo M; Rubiera M; Montaner J; Santamarina E; Delgado-Mederos R; Arenillas JF; Huertas R; Purroy F; Delgado P; Alvarez-Sabín J
    Stroke; 2006 Feb; 37(2):425-9. PubMed ID: 16373632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Clot Composition Influences Fibrinolysis in the Acute Phase of Stroke: A Proteomic Study of Cerebral Thrombi.
    Doche E; Sulowski C; Guigonis JM; Graslin F; Casolla B; Hak JF; Carle X; Brunel H; Lindenthal S; Martin JC; Pourcher T; Suissa L;
    Stroke; 2024 Jul; 55(7):1818-1829. PubMed ID: 38771990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle Mice Are Sensitive to Hypoxia/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator Treatment.
    Sun YY; Lee J; Huang H; Wagner MB; Joiner CH; Archer DR; Kuan CY
    Stroke; 2017 Dec; 48(12):3347-3355. PubMed ID: 29127268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Simulations of Thrombolytic Therapy in Acute Ischaemic Stroke.
    Piebalgs A; Gu B; Roi D; Lobotesis K; Thom S; Xu XY
    Sci Rep; 2018 Oct; 8(1):15810. PubMed ID: 30361673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
    Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
    Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background.
    Tabrizi P; Wang L; Seeds N; McComb JG; Yamada S; Griffin JH; Carmeliet P; Weiss MH; Zlokovic BV
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2801-6. PubMed ID: 10559029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
    Niessen F; Hilger T; Hoehn M; Hossmann KA
    Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion.
    Vilas D; Gomis M; Blanco M; Cortés J; Millán M; Pérez de la Ossa N; Dorado L; López-Cancio E; Suñol A; Dávalos A
    Chronobiol Int; 2012 Dec; 29(10):1383-9. PubMed ID: 23130962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbubble-Mediated Sonothrombolysis Improves Outcome After Thrombotic Microembolism-Induced Acute Ischemic Stroke.
    Lu Y; Wang J; Huang R; Chen G; Zhong L; Shen S; Zhang C; Li X; Cao S; Liao W; Liao Y; Bin J
    Stroke; 2016 May; 47(5):1344-53. PubMed ID: 27048701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
    Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
    Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots.
    Colasuonno M; Palange AL; Aid R; Ferreira M; Mollica H; Palomba R; Emdin M; Del Sette M; Chauvierre C; Letourneur D; Decuzzi P
    ACS Nano; 2018 Dec; 12(12):12224-12237. PubMed ID: 30427660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance.
    Peña-Martínez C; Durán-Laforet V; García-Culebras A; Ostos F; Hernández-Jiménez M; Bravo-Ferrer I; Pérez-Ruiz A; Ballenilla F; Díaz-Guzmán J; Pradillo JM; Lizasoain I; Moro MA
    Stroke; 2019 Nov; 50(11):3228-3237. PubMed ID: 31526124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mouse model of thromboembolic stroke.
    Chen Y; Zhu W; Zhang W; Libal N; Murphy SJ; Offner H; Alkayed NJ
    J Neurosci Methods; 2015 Dec; 256():203-11. PubMed ID: 26386284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.